Michael H. Goldstein
President at Aurion Biotech, Inc.
Network origin in Michael H. Goldstein first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 13 | |
Aurion Biotech, Inc.
 Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021.
7
| Holding Company | Medical/Nursing Services | 7 |
Aramis Biosciences, Inc.
 Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals.
4
| Holding Company | Pharmaceuticals: Major | 4 |
| Subsidiary | Pharmaceuticals: Generic | 4 | |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA.
2
| Non-Profit Organization | Medical/Nursing Services | 2 |
University of Florida College of Medicine
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael H. Goldstein via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
CorneaGen, Inc.
 CorneaGen, Inc. Medical SpecialtiesHealth Technology CorneaGen, Inc. engages in the provision of cornea care services. It offers precision cut corneal tissue, Descemet’s Membrane Endothelial Keratoplasty, and Descemet’s Stripping Automated Endothelial Keratoplasty. The firm's products include EndoSerter, Geuder Glass Cannula, and Donor Trephine Punch. The company was founded in 2016 and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Doctorate Degree | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
MTrap, Inc.
 MTrap, Inc. Miscellaneous Commercial ServicesCommercial Services MTrap, Inc. engages in the development of novel therapeutic devices that interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment. The company was founded by Maybelle L. Jordan and is headquartered in Huntington, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Epiva Biosciences, Inc.
 Epiva Biosciences, Inc. BiotechnologyHealth Technology Epiva Biosciences, Inc. develops immunobiotic therapeutics. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member President | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
IOR Partners LLC
 IOR Partners LLC Medical SpecialtiesHealth Technology IOR Partners LLC develops office-based surgery suites. The company was founded by Rick Prell and is headquartered in Boulder City, NV. | Medical Specialties | Director/Board Member Director/Board Member | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| EDWARDS LIFESCIENCES CORPORATION | Medical Specialties | Human Resources Officer Director/Board Member | |
| LENSAR, INC. | Medical Specialties | Director/Board Member Chairman | |
Equinox Ophthalmic, Inc.
 Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Flying L Management LLC
 Flying L Management LLC Investment ManagersFinance Flying L Management LLC (Flying L Management) is a venture capital firm founded in 2016. The firm is headquartered in Newport beach, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Aviana Molecular Technologies LLC
 Aviana Molecular Technologies LLC Medical SpecialtiesHealth Technology Aviana Molecular Technologies LLC develops technologies for point of care diagnostic of infections. It develops a miniaturized biosensor capable of attaching to a smartphone or smart device through Bluetooth or other wireless connections. The company's diagnostic system is a diagnostic platform that can accurately, detect a target infectious disease, biomarkers or proteins in both clinical and scientific research settings. Its platform uses the latest developments in cellular communications, semiconductor electronics, micro-fluidics and manufacturing methods to create a unique point-of-care diagnostic platform to detect biomarkers or infections. The company was founded by Vanaja Ragavan in 2008 and is headquartered in Orlando, FL. | Medical Specialties | Director/Board Member Chairman | |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Pharmaceuticals: Other | Director/Board Member Chairman | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Founder | |
| AXCA HEALPAR | Biotechnology | Founder Founder | |
| Chiron Vision Corp. | Chief Executive Officer Sales & Marketing | ||
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Founder | |
OCTANe
 OCTANe Miscellaneous Commercial ServicesCommercial Services OCTANe connects people and ideas with capital and resources for technology growth in Orange County. It stimulates technology job growth and wealth creation; helps entrepreneurs turn ideas into successful businesses; helps companies connect with funding and growth resources; helps senior executives access intelligence, new technologies, and talent; helps develop technology business leaders; and creates a forum for technology company leaders to have an impact on the future. The company offers LaunchPad, a pro-bono accelerator for startup companies in the technology, life science, and clean tech industries. The company was founded in 2002 and is headquartered in Aliso Viejo, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Vialase, Inc.
 Vialase, Inc. Medical/Nursing ServicesHealth Services Vialase, Inc. provides healthcare services. The company is headquartered in Aliso Viejo, CA. | Medical/Nursing Services | Director/Board Member Chairman | |
| T2 BIOSYSTEMS, INC. | Medical Specialties | Director/Board Member Founder | |
LS Dissolution, Inc.
 LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Chemicals: Major Diversified | Founder Founder | |
Neurolens, Inc.
 Neurolens, Inc. Electronic ComponentsElectronic Technology Neurolens, Inc. is a company that commercializes breakthrough technology to improve vision care. The company's patented contoured prism technology provides visual comfort for the nearly 65% of US adults who complain of headaches, neck/shoulder pain, and eyestrain when using digital devices, reading, or doing detail work. The company is based in Coppell, TX. Inspired by a breakthrough discovery linking optometry and neurology, Neurolens is unlocking a new dimension of vision care. The Neurolens contoured prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. The technology is only available to independent eye care providers. The company was founded in 2012 by Davis Corley, and Pierre Bertrand has been the CEO of the company since 2019. | Electronic Components | Director/Board Member Director/Board Member | |
| Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree | |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
eyeonics, Inc.
 eyeonics, Inc. Electronic ComponentsElectronic Technology eyeonics, Inc. designs, develops, manufactures and sells premium intraocular lenses. Its lenses are implantable devices that replace the natural lens in the human eye, typically after the natural lens has developed cataracts that can significantly impair vision. The firm's products are designed to both replace a cataractous lens and correct a refractive error. The company was founded by Andrew J. Corley and Stuart J. Cumming in 1998 and is headquartered in Aliso Viejo, CA. | Electronic Components | Director/Board Member Director/Board Member | |
WaveTec Vision Systems, Inc.
 WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA. | Electronic Components | Director/Board Member Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| RXSIGHT, INC. | Electronic Components | Director/Board Member | |
DOSE Medical Corp.
 DOSE Medical Corp. Medical DistributorsDistribution Services DOSE Medical Corp. engages in the provision of investment services. The company is headquartered in San Clemente, CA. | Medical Distributors | Director/Board Member | |
| The Indiana University School of Medicine | College/University | Corporate Officer/Principal | |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Medical Specialties | Director/Board Member | |
Minnesota Eye Consultants PA
 Minnesota Eye Consultants PA Medical/Nursing ServicesHealth Services Minnesota Eye Consultants PA provides ophthalmology services. Its services include Lasik, Cataract, Glaucoma, Corena, Oculofacial and Dry Eye Center. The company was founded by Richard L. Lindstrom and is headquartered in Minneapolis, MN. | Medical/Nursing Services | Chief Executive Officer | |
ForSight VISION5, Inc.
 ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Electronic Equipment/Instruments | Director/Board Member | |
| GLAUKOS CORPORATION | Medical Specialties | Chairman |
Statistics
International
| United States | 50 |
| China | 2 |
Sectoral
| Health Technology | 27 |
| Finance | 6 |
| Commercial Services | 6 |
| Electronic Technology | 6 |
| Consumer Services | 4 |
Operational
| Director/Board Member | 274 |
| Founder | 75 |
| Corporate Officer/Principal | 66 |
| Chairman | 63 |
| Independent Dir/Board Member | 57 |
Most connected contacts
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Richard Lindstrom | 50 |
| Bill Link | 43 |
| Arnold Lewis Oronsky | 35 |
| Andrew ElBardissi | 32 |
| David Berry | 31 |
| Mark Levin | 26 |
| Wendy Dixon | 25 |
| Cameron Wheeler | 20 |
| David Tierney | 19 |
| Thomas Frinzi | 18 |
| Gregory Perry | 16 |
| Paul Chaney | 12 |
| Patrick P. Lally | 10 |
| Christine Z. McCauley | 10 |
- Stock Market
- Insiders
- Michael H. Goldstein
- Company connections
